RARE
Ultragenyx Pharmaceutical Inc.
$29.96
-$0.34(-1.12%)
38
Overall
--
Value
27
Tech
50
Quality
Market Cap
$2.85B
Volume
1.34M
52W Range
$25.81 - $60.37
Target Price
$85.85
EPS Estimates Overview
| Current Quarter | $-1.21 | Next Quarter | $-1.13 |
| Current Year | $-5.18 | Next Year | $-3.87 |
| QoQ Growth | +6.6% | YoY Growth | +25.3% |
| 3Y EPS CAGR | +1.6% | Target Price | $85.85 |
| Consensus | Buy | Upside | +186.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $29.96 | -1.1% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW